Neuenhahn, M., & Schmitt, M. (2017). Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. Leukemia, 31(10), . https://doi.org/10.1038/leu.2017.16
Chicago Style (17th ed.) CitationNeuenhahn, Michael, and Michael Schmitt. "Transfer of Minimally Manipulated CMV-specific T Cells from Stem Cell or Third-party Donors to Treat CMV Infection After Allo-HSCT." Leukemia 31, no. 10 (2017). https://doi.org/10.1038/leu.2017.16.
MLA (9th ed.) CitationNeuenhahn, Michael, and Michael Schmitt. "Transfer of Minimally Manipulated CMV-specific T Cells from Stem Cell or Third-party Donors to Treat CMV Infection After Allo-HSCT." Leukemia, vol. 31, no. 10, 2017, https://doi.org/10.1038/leu.2017.16.
Warning: These citations may not always be 100% accurate.